1. A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging. (December 2022) Authors: Liu, Di; He, Hongliang; Kong, Fei; Cao, Yixiang; Zang, Fengchao; Ma, Ming; Gu, Ning; Zhang, Yu Journal: Nano today Issue: Volume 47(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗